Biofrontera Inc.
BFRI

$7.58 M
Marketcap
$0.98
Share price
Country
$-0.02
Change (1 day)
$3.90
Year High
$0.61
Year Low

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

marketcap

Stock price history for Biofrontera Inc. (BFRI)

Highest end of day price: $263.40 USD on 2021-12-23

Lowest end of day price: $0.67 USD on 2024-11-18

Stock price history of Biofrontera Inc. from 2021 to 2024